🟢 Decoy Therapeutics is trading 11.07% up in pre-market with no clear catalyst identified

Decoy Therapeutics is trading at $2.91, 11.07% up in pre-market, with no clear catalyst identified.

• The company announced a September 9–10 investor conference appearance, including a September 10 corporate presentation at 1:45 p.m.
• No earnings, regulatory decision, financing, or other clear catalyst directly explaining the pre-market gain was identified.
• Broader markets are weaker, and shares closed at $2.63 on September 8, 2026.